Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system

por Han, Lei, Chen, Junsheng, Ding, Kai, Zong, Huifang, Xie, Yueqing, Jiang, Hua, Zhang, Baohong, Lu, Huili, Yin, Weihan, Gilly, John, Zhu, Jianwei
Publicado 2017

RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis

por Li, Chaodong, Ge, Mei, Chen, Daijie, Sun, Tao, Jiang, Hua, Xie, Yueqing, Lu, Huili, Zhang, Baohong, Han, Lei, Chen, Junsheng, Zhu, Jianwei
Publicado 2020

Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4

por Hao, Shuai, Xu, Shuyi, Li, Liangzhu, Li, Yaxian, Zhao, Meiqi, Chen, Junsheng, Zhu, Shunying, Xie, Yueqing, Jiang, Hua, Zhu, Jianwei, Wu, Mingyuan
Publicado 2022

A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer

por Zhou, Yuexian, Zong, Huifang, Han, Lei, Xie, Yueqing, Jiang, Hua, Gilly, John, Zhang, Baohong, Lu, Huili, Chen, Jie, Sun, Rui, Pan, Zhidi, Zhu, Jianwei
Publicado 2020

Binding domain on CD22 molecules contributing to the biological activity of T cell-engaging bispecific antibodies

por Chen, Jie, Pan, Zhidi, Han, Lei, Liu, Junjun, Yue, Yali, Xiao, Xiaodong, Zhang, Baohong, Wu, Mingyuan, Yuan, Yunsheng, Bian, Yanlin, Jiang, Hua, Xie, Yueqing, Zhu, Jianwei
Publicado 2023

A Novel Bispecific Antibody Targeting CD3 and Lewis Y with Potent Therapeutic Efficacy against Gastric Cancer

por Chen, Jie, Pan, Zhidi, Han, Lei, Zhou, Yuexian, Zong, Huifang, Wang, Lei, Sun, Rui, Jiang, Hua, Xie, Yueqing, Yuan, Yunsheng, Wu, Mingyuan, Bian, Yanling, Zhang, Baohong, Zhu, Jianwei
Publicado 2021

Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement

por Pan, Zhidi, Chen, Jie, Xiao, Xiaodong, Xie, Yueqing, Jiang, Hua, Zhang, Baohong, Lu, Huili, Yuan, Yunsheng, Han, Lei, Zhou, Yuexian, Zong, Huifang, Wang, Lei, Sun, Rui, Zhu, Jianwei
Publicado 2022

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD

por Ma, Hang, Guo, Yingying, Tang, Haoneng, Tseng, Chien-Te K., Wang, Lei, Zong, Huifang, Wang, Zhenyu, He, Yang, Chang, Yunsong, Wang, Shusheng, Huang, Haiqiu, Ke, Yong, Yuan, Yunsheng, Wu, Mingyuan, Zhang, Yuanyuan, Drelich, Aleksandra, Kempaiah, Kempaiah Rayavara, Peng, Bi-Hung, Wang, Ailin, Yang, Kaiyong, Yin, Haiyang, Liu, Junjun, Yue, Yali, Xu, Wenbo, Zhu, Shuangli, Ji, Tianjiao, Zhang, Xiaoju, Wang, Ziqi, Li, Gang, Liu, Guangchun, Song, Jingjing, Mu, Lingling, Xiang, ZongShang, Song, Zhangyi, Chen, Hua, Bian, Yanlin, Zhang, Baohong, Chen, Hui, Zhang, Jiawei, Liao, Yunji, Zhang, Li, Yang, Li, Chen, Yi, Gilly, John, Xiao, Xiaodong, Han, Lei, Jiang, Hua, Xie, Yueqing, Zhou, Qiang, Zhu, Jianwei
Publicado 2022